Therefore, we quantified the expression of ectonucleotidase CD39 on PD-1+ CD8+ T cells, which has recently been described as a specific marker of tumor-reactive, antigen-specific tumor-infiltrating CD8+ T cells31–33. The gene discussed is ENTPD1; the disease is neoplasm.